Nihon Chouzai Co.Ltd

PINK:NHCZF USA Other
Market Cap
$480.56 Million
Market Cap Rank
#16075 Global
#6229 in USA
Share Price
$16.03
Change (1 day)
+0.00%
52-Week Range
$16.03 - $16.03
All Time High
$975417.16
About

Nihon Chouzai Co.,Ltd. engages in the management of insurance dispensing pharmacy chain in Japan. The company also engages in the manufacture and sale of generic pharmaceutical products to medical institutions and pharmacies. It also provides services for nursing care facilities, life and medical insurance services, and dispensing pharmacy development. The company was founded in 1980 and is headq… Read more

Nihon Chouzai Co.Ltd (NHCZF) - Net Assets

Latest net assets as of March 2024: $58.35 Billion USD

Based on the latest financial reports, Nihon Chouzai Co.Ltd (NHCZF) has net assets worth $58.35 Billion USD as of March 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($195.09 Billion) and total liabilities ($136.74 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $58.35 Billion
% of Total Assets 29.91%
Annual Growth Rate 14.22%
5-Year Change 23.96%
10-Year Change N/A
Growth Volatility 24.5

Nihon Chouzai Co.Ltd - Net Assets Trend (2015–2024)

This chart illustrates how Nihon Chouzai Co.Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Nihon Chouzai Co.Ltd (2015–2024)

The table below shows the annual net assets of Nihon Chouzai Co.Ltd from 2015 to 2024.

Year Net Assets Change
2024-03-31 $58.35 Billion +3.31%
2023-03-31 $56.48 Billion +6.82%
2022-03-31 $52.88 Billion +6.03%
2021-03-31 $49.87 Billion +5.94%
2020-03-31 $47.07 Billion +14.61%
2019-03-31 $41.07 Billion -1.04%
2018-03-31 $41.51 Billion +13.88%
2017-03-31 $36.45 Billion +12.24%
2016-03-31 $32.47 Billion +84.15%
2015-03-31 $17.63 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Nihon Chouzai Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 296.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2024)

Component Amount Percentage
Retained Earnings $47.02 Billion 80.58%
Other Components $11.33 Billion 19.42%
Total Equity $58.35 Billion 100.00%

Nihon Chouzai Co.Ltd Competitors by Market Cap

The table below lists competitors of Nihon Chouzai Co.Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nihon Chouzai Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 56,483,000,000 to 58,351,000,000, a change of 1,868,000,000 (3.3%).
  • Net income of 2,553,000,000 contributed positively to equity growth.
  • Dividend payments of 749,000,000 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $2.55 Billion +4.38%
Dividends Paid $749.00 Million -1.28%
Other Changes $64.00 Million +0.11%
Total Change $- 3.31%

Book Value vs Market Value Analysis

This analysis compares Nihon Chouzai Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.01x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-03-31 $1139.26 $16.03 x
2018-03-31 $1297.41 $16.03 x
2019-03-31 $1369.51 $16.03 x
2020-03-31 $1569.69 $16.03 x
2021-03-31 $1662.95 $16.03 x
2022-03-31 $1763.30 $16.03 x
2023-03-31 $1888.16 $16.03 x
2024-03-31 $1950.41 $16.03 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nihon Chouzai Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.38%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.75%
  • • Asset Turnover: 1.74x
  • • Equity Multiplier: 3.34x
  • Recent ROE (4.38%) is below the historical average (11.25%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 15.75% 1.53% 1.40x 7.38x $1.01 Billion
2016 19.49% 2.89% 1.39x 4.85x $3.08 Billion
2017 12.73% 2.08% 1.25x 4.89x $993.50 Million
2018 14.71% 2.53% 1.29x 4.50x $1.95 Billion
2019 9.23% 1.54% 1.38x 4.35x $-316.90 Million
2020 14.23% 2.49% 1.45x 3.94x $1.99 Billion
2021 7.09% 1.27% 1.50x 3.74x $-1.45 Billion
2022 7.01% 1.24% 1.67x 3.38x $-1.58 Billion
2023 7.89% 1.42% 1.69x 3.28x $-1.19 Billion
2024 4.38% 0.75% 1.74x 3.34x $-3.28 Billion

Industry Comparison

This section compares Nihon Chouzai Co.Ltd's net assets metrics with peer companies in the Other industry.

Industry Context

  • Industry: Other
  • Average net assets among peers: $21,282,152,580
  • Average return on equity (ROE) among peers: 31.25%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nihon Chouzai Co.Ltd (NHCZF) $58.35 Billion 15.75% 2.34x $162.79 Million
Arçelik Anonim Sirketi (ACKAF) $59.56 Billion 12.87% 3.33x $19.95K
Argo Group US Inc. 6.5% SR NTS 42 (ARGD) $1.23 Billion -15.51% 0.05x $232.01K
American Crystal Sugar Company PFD REST NON DIV (ASCS) $316.55 Million 254.25% 1.77x $54.72 Million
Autobacs Seven Co. Ltd (ATBSF) $127.35 Billion 4.24% 0.47x $167.34K
Brookfield Asset Management Inc FR PRF PERPETUAL CAD 25 Ser 2 Cls A (BKFAF) $11.77 Billion 6.69% 3.72x $76.46K
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) $5.08 Billion 14.69% 0.67x $9.45 Million
BOL Bancshares Inc. PFD (BOLBP) $11.94 Million 0.62% 6.68x $0.91
NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) $3.36 Billion 11.17% 0.52x $237.68K
Canadian Utilities Limited 2ND PFD SER Y (CNAUF) $4.14 Billion 10.45% 1.28x $142.90K
Central Parking Finance Trust PFD TR CV SECS (CRLKP) $374.10 13.04% 2.96x $224.78K